Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev)

Radiotherapy (RT), together with a direct cytolytic effect on tumor tissue, also elicits systemic immunological events, which sometimes result in the regression of distant metastases (abscopal effect). We have shown the safety and anti-tumor activity of a novel metronomic chemotherapy (mCH) regimen...

Descripción completa

Detalles Bibliográficos
Autores principales: Pastina, Pierpaolo, Nardone, Valerio, Botta, Cirino, Croci, Stefania, Tini, Paolo, Battaglia, Giuseppe, Ricci, Veronica, Cusi, Maria Grazia, Gandolfo, Claudia, Misso, Gabriella, Zappavigna, Silvia, Caraglia, Michele, Giordano, Antonio, Aldinucci, Donatella, Tassone, Pierfrancesco, Tagliaferri, Pierosandro, Pirtoli, Luigi, Correale, Pierpaolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652673/
https://www.ncbi.nlm.nih.gov/pubmed/29100279
http://dx.doi.org/10.18632/oncotarget.20411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652673/
https://www.ncbi.nlm.nih.gov/pubmed/29100279
http://dx.doi.org/10.18632/oncotarget.20411

Ejemplares similares